Newsletter · · Ashutosh Agarwal

GLP-1 Drugs Begin Biting the Fast Food Dollar and Wingstop Guides to Global Growth - QSR Value Wars - Week of July 13, 2026

QSR and restaurants newsletter for the week of July 13, 2026. With the big-chain value war quiet, the tape turned to weight-loss drugs measurably trimming the food dollar, Wingstop's CEO laying out the cleanest unit-economics pitch of the week, brand chiefs at Moe's and Schlotzky's fighting the value war one rung down the ladder, Cava's clean-but-expensive setup, and a two-sided debate over whether the low-end consumer is fine or quietly cracking.

QSR Value Wars

Week of July 13, 2026: GLP-1 Drugs Begin Biting the Fast Food Dollar and Wingstop Guides to Global Growth

Quiet week on the front lines of the value-menu war. Nobody from McDonald's, Taco Bell, Wendy's or Burger King showed up on a podcast to talk traffic or margins, so the loudest fight in fast food went unrefereed for seven days. But that quiet let a slower, bigger story get a word in, the one about the weight-loss drugs and what they are doing to how much people eat, and where. It is the kind of thing that does not show up in a single quarter and then shows up in all of them. So this week we lead there, then get to the operator who actually gave us numbers (Wingstop's CEO), the value-menu playbook two brand chiefs walked through, one very expensive fast-casual darling, and the endless argument about whether the low-end consumer is fine or quietly cracking.

TL;DR

  • A June 2026 study says weight-loss drugs are pulling roughly £800 million a year out of UK supermarket spending, and one user-slash-journalist was blunt about cutting her own takeaways and restaurant orders, the demand headwind restaurants keep waving off is starting to get measured. The Economics Show
  • Separately, a doctor's podcast passed along the same street-level rumor: food companies are "getting nervous" because people on these drugs are eating fewer packaged foods and "their sales are going down." DoctorPodcasts / Cykiert Files
  • Wingstop's CEO laid out the cleanest growth math of the week: ~$2 million in sales per store run by as few as 14 people, 95% of orders going out the door, and a goal of 10,000 stores worldwide from 3,000 today. CEO Spotlight
  • Two brand chiefs (Moe's and Schlotzky's) explained how the value fight actually gets fought below the big chains, cheap "value plays" that lift traffic, and a smaller store built specifically so the franchisee can make money. Fast Casual Nation
  • Cava got a fair hearing and a hard pass from one investor: best traffic in the group (up 6–7%), a clean balance sheet, and a valuation he called "too rich for me." InvestTalk
  • A credit strategist and PepsiCo are looking at the same consumer and seeing opposite things: card data says spending is "remarkably robust," PepsiCo says shoppers are "worse than what we had anticipated." Van Hesser's 3 Things in Credit (KBRA)

What's new

The weight-loss drugs finally put a number on the food they are taking away

For two years the standard restaurant-management line on GLP-1s, the family of weight-loss and diabetes drugs like Ozempic, Wegovy and Mounjaro, has been a shrug: too few people on them to matter, and anyway heavy users were never the core customer. This week two podcasts quietly chipped at that.

On The Economics Show (July 10), host Soumaya Keynes talked with the Financial Times' consumer editor Claer Barrett, who is herself on the drugs and has lost a lot of weight, and Harvard economist Rebecca Diamond. Barrett pointed to a study out in June from World Panel that tracked how GLP-1 users shop: in the UK, it reckoned, roughly £800 million a year less is being spent at the supermarket because of these drugs.

More telling than the headline number was Barrett describing her own wallet. She spends about £200–250 a month on the drugs, and said she is clawing a good chunk of that back:

"I'm definitely saving a good chunk of that money, especially by not buying takeaways, not ordering so much in restaurants, and buying fewer things when I go to the supermarket."

That is the sentence restaurants should sit with. It is not that she stopped eating, she is buying more expensive healthy food, more protein, fewer biscuits. It is that the impulse spend, the takeaway and the restaurant order, is exactly what gets cut first.

Two honest caveats, both from Barrett herself. In the UK the effect is still "quite hard to pick up in the aggregate data... take-up rates of GLPs are not that high so far." And she expects the bite to be bigger in the US, where far more people are on the drugs, "every other advert is an advert for a GLP." So this is early, and it is louder in America than the UK number suggests. Diamond's own new working paper was about a different angle entirely, she found women who start these drugs while out of work raise their employment rate by about 29 percentage points a couple of years later, but she noted in passing that the drugs seem to dull impulsive behavior generally, not just overeating. Fewer impulse buys is, again, the restaurant's problem.

The same rumor surfaced from a completely different corner. On DoctorPodcasts / Cykiert Files (July 4), the host told his guest, a public-health nutrition researcher, that "some of the food companies are getting nervous because of the GLP-1 drugs... their sales are going down." She agreed she had heard the same and said food companies are "very much aware of the effect that GLP-1s are having on cravings" and are "actively working to continue to sell their products" in spite of it. That is anecdote, not data, but it is the same anecdote coming from an FT editor's grocery receipts and a doctor's podcast in the same week.

Why it matters: this is a slow-drip demand headwind, not a quarter-end event. It works against ticket (people ordering less per visit) and against the exact low-price, impulse-driven occasion that value menus are built to win. It does not sink anyone this year. But if you are underwriting years of same-store-sales growth for the packaged-food-adjacent and value-QSR names, this is the assumption to start stress-testing now rather than after it shows up in the numbers.

Wingstop's CEO gave the numbers everyone else skipped

The one operator who actually put figures on the table was Michael Skipworth, President and CEO of Wingstop, on CEO Spotlight (July 7). The model he described is the one bulls have loved for years, said plainly:

  • Over 3,000 restaurants across 17 markets today, with a stated goal of becoming a top-10 global restaurant brand, which he said means more than 10,000 Wingstops eventually.
  • They opened close to 500 restaurants last year. The long-term target for new-unit growth is 10% a year, but "recently, particularly last year and what we actually estimate for this year, we're opening at a much higher growth rate than that."
  • The reason franchisees keep signing up is the store-level economics. A Wingstop doing about $2 million a year in sales can be run "with as few as 14 members," that is, 14 employees. Skipworth called the labor model "a little bit of our secret sauce" and said it delivers "some of the best returns for our brand partners that are in the industry."
  • Roughly 95% of sales "go out the door", pickup and delivery, not dine-in, so the stores do not need a drive-thru or a big footprint. They are typically small in-line units leaning on the app and web.

Two things worth flagging beyond the growth story. First, on commodity costs, usually a wing chain's nightmare, Skipworth said their supply-chain setup, built on long-term supplier contracts, is now "almost a moat," having moved the business from spot-market exposure to "pretty insulated from volatility" with predictable food costs for franchisees. Second, they have rolled out a new AI-driven "kitchen operating system" to get ahead of demand in the store. This is a CEO doing a friendly local-radio interview, so treat it as the polished version, no comps, no margin figures. But the unit-economics pitch is intact and, if anything, the pace of openings sounds like it is running ahead of the 10% long-term algorithm, which is what the multiple has always been paying for.

The value fight, one rung down the ladder

The big-chain value war was silent this week, but two brand chiefs showed how the same fight plays out for smaller franchised brands, and it is really a fight about franchisee profit, not headlines.

On Fast Casual Nation (July 7), Mike Smith, chief brand officer of Moe's Southwest Grill (about 550 restaurants), put the value point simply: "Our recent value plays have done really well in the marketplace, and we're excited about growing traffic and sales." Same story the majors are living, lead with a cheap offer, buy the traffic. What was more interesting was his explanation of why Moe's runs almost no drive-thrus (fewer than 20 across the whole system): the average Moe's burrito or bowl has 11 to 13 ingredients, and taking that order through a speaker, often between an employee and a customer who do not share a first language, is a recipe for wrong food. So Moe's pushes customers to the app and "order my usual" instead. It is a small detail with a real lesson: the drive-thru economics that make McDonald's and Taco Bell hum do not transfer to a build-your-own concept, which is part of why customization-heavy chains lean so hard on digital.

The sharper investor point came from Donna Varner, chief brand officer of Schlotzky's (a sister brand under parent GoToFoods). Schlotzky's just changed its new-store blueprint to a 2,100-square-foot "entry-level prototype," and Varner was explicit that it was designed "leaning into first franchisee and level economics," a smaller, cheaper box, drive-thru optional, kiosks up front, built so a franchisee can actually clear a return and so the brand can grow into new markets again. (She also walked through renaming the chain back to "Schlotzky's Deli" after research found two-thirds of people who knew the brand already called it that, and some who didn't thought "Schlotzky's" was a dry cleaner.) The through-line across both brands: the unit of competition below the mega-chains is the franchisee's profit-and-loss, and the current answer is a smaller store plus a value offer plus digital ordering. That is the same equation squeezing the big franchised systems, just without the press coverage.

The names in play

Only worth a few lines this week, because the coverage was pundit-and-chart, not operator.

Cava got the most thoughtful treatment. On InvestTalk (July 7), the host fielded a listener question and gave Cava real credit: revenue up 32% year over year, a restaurant-level profit margin of 25% ("pretty solid"), a nearly debt-free balance sheet with about $400 million of cash, and, the standout, traffic growth of 6–7%, which he called "far and above any other fast-casual or even casual-dining peer." (For context, traffic is the count of actual visits, the hardest and cleanest number to grow; most of the industry is buying transactions with discounts.) And yet he passed, because at roughly $71 a share the stock trades around 118 times forward earnings and 11 times book value. His line: "The fundamentals are pretty much as clean as it gets within the fast-casual space, but it's just too rich for me." He also flagged that profitability is expected to dip near-term, operating margin contracting from 6.7% to 4.8%, with the next earnings report due August 18. That is the whole Cava debate in one caller segment: nobody disputes the business; everybody disputes the price.

Shake Shack and Dutch Bros showed up only as charts, and ugly ones. On TraderMerlin (July 10), the host noted Shake Shack near $58.60, down roughly 50% from its April 20 high, and the chat piled on the same complaint you hear in the parking lot: it is priced like Five Guys when people would rather get a burger at In-N-Out or Habit. On Stock Market Today With IBD (July 10), Dutch Bros was called a "terrible-looking chart," but one host made the bull case on the business rather than the tape: think of it as "In-N-Out that's public," a tiny drive-thru stand run by three friendly people, with a completely different cost structure than a big-box Starbucks. Same segment noted money quietly rotating into beaten-up restaurant names, Cheesecake Factory, Brinker (Chili's) and Texas Roadhouse all got a mention as setting up. File that under sentiment, not fundamentals.

The debate: is the low-end consumer fine, or quietly cracking?

This is the argument that decides the value-wars thesis, and this week it got a proper two-hander, from one podcast.

On Van Hesser's 3 Things in Credit (July 10), KBRA's chief strategist walked through Bank of America's latest read on its own customers' card spending, and admitted the strength "caught us by surprise." Total spending per household was up 5.1% year over year, the biggest gain in almost four years. Crucially for restaurants, he said the lower- and middle-income groups grew spending 4.1% and 4.3% respectively, both with "robust" discretionary spending, and only about 1% of households looked to have stopped buying discretionary things like clothing or restaurant meals. BofA's own words: "little sign of shift in consumer behavior that would suggest weakness."

Then Hesser steel-manned the other side against himself. Severe credit-card delinquencies are at or near all-time highs. The savings rate has fallen well below normal. The Federal Reserve's annual household report found 16% of adults did not pay all their bills the prior month and 30% rarely or never have money left over at month-end, including 15% of people earning over $100,000. And, pointedly, this very week PepsiCo said on its results that "the consumer is worse than what we had anticipated and it's driven mainly by gas prices." His conclusion was not a shrug but a lean: aggregate spending is holding up on the wealth effect at the top, but the bottom rung, still about 39% of all consumer spending, faces real headwinds, and he expects consumption to slow in the second half.

Put the two threads together and you get this week's actual signal. The bull case for value menus is that the low-end customer is still spending and still trades down to your cheap combo. The bear case is not that spending collapses, it is that it slowly erodes from two directions at once: gas prices and stretched budgets on one side, and, further out, weight-loss drugs quietly trimming the impulse food occasion on the other. Neither is a single-quarter story. Both cut against the same thing, the frequency and size of the cheap, spontaneous restaurant visit, which is precisely what the value war is fighting over. The card data says relax; the drug data and PepsiCo say don't get comfortable.

What changed vs last week

Last week's issue was about one franchisee's unusually bullish read on Burger King; the week before, about value wars separating winners from losers as the low end faded. Neither of those principals came back to the microphone this week. What genuinely moved the conversation forward was the GLP-1 thread crossing from "someday" into a measured number (£800m of UK grocery spend, plus a first-person account of cut takeaways and restaurant orders) and the low-end debate getting a fresh, specific data print (BofA's +5.1%, offset by PepsiCo's blunt caution) rather than the usual hand-waving. If you tracked only one new thing this week, track the drugs.